Celularity’s Barach Trust Buy‑In Signals Strategic Capital‑Raising Shift
Barach Family Trust’s buy‑out of 192K convertible notes at $1.50 boosts Celularity’s capital base, signaling confidence in its upcoming clinical milestones.
3 minutes to read
CELULARITY INC